Core Insights - The Lovesac Company has launched a campaign called "[SIT]UATIONSHIP" in collaboration with reality star Amanda Batula, encouraging consumers to upgrade their couches and move away from subpar furniture relationships [1] Company Overview - The Lovesac Company, based in Stamford, Connecticut, is a technology-driven furniture brand that designs, manufactures, and sells high-quality, durable furniture [1] - The company's product line includes modular couches known as Sactionals, premium foam beanbag chairs called Sacs, and innovative home theater systems [1] - Lovesac emphasizes responsible production and innovation, having received awards for sustainability and product design [1] Campaign Details - The "[SIT]UATIONSHIP" campaign aims to address the issue of consumers settling for inadequate couches, paralleling modern dating culture where many find themselves in "situationships" [1] - The campaign features a hotline where consumers can share their couch stories for a chance to win a new Lovesac couch, running from February 12 to February 22 [1] - Amanda Batula expresses her commitment to quality and intentionality in her living space, aligning with Lovesac's philosophy of providing furniture that lasts [1] Market Positioning - Lovesac positions its products as high-quality and designed to evolve with customers' lives, contrasting with the notion of settling for "good enough" furniture [1] - The company markets its products primarily online, supported by physical showrooms and partnerships with third-party retailers [1]

Core Viewpoint - Cannara Biotech Inc. is set to host an investor webcast presentation on February 19, 2026, to discuss key aspects of its business and engage with investors through a Q&A session [1][2]. Company Overview - Cannara Biotech Inc. is a vertically integrated producer of premium-grade cannabis products at affordable prices, operating two mega facilities in Québec that cover over 1,600,000 square feet [1][3]. - The company has the potential for an annualized cultivation output of 100,000 kg, leveraging Québec's low electricity costs to maintain affordability [3].

Core Viewpoint - Cannara Biotech Inc. has completed a strategic non-brokered private placement with Phoenician Capital LLC, raising C$6,300,000 through the issuance of 3,000,000 common shares at a price of C$2.10 per share, which is a 16% premium over the closing price prior to the announcement [1][2]. Group 1: Private Placement Details - The proceeds from the private placement will be utilized for working capital and strategic investments, including capital investments in the Valleyfield Facility and operational expansion [2]. - The common shares issued are subject to a statutory hold period of four months and one day, in accordance with Canadian securities laws [3]. Group 2: Management Commentary - The CEO of Cannara, Zohar Krivorot, stated that the investment aligns with the company's expansion strategy and reflects confidence in its operational model [3]. - John Khabbaz, from Phoenician, expressed support for Cannara's focus on operational discipline and long-term value creation [3]. Group 3: Secondary Share Sale - Zohar Krivorot has agreed to sell 333,333 common shares to Phoenician at the same price of C$2.10 per share, which is intended to offset personal tax losses [5]. - Following the secondary share sale, Krivorot's ownership will decrease from approximately 26.99% to 25.83% of the issued and outstanding common shares [6]. Group 4: Company Overview - Cannara Biotech Inc. is a vertically integrated producer of premium-grade cannabis products, operating two facilities in Québec with a total area of over 1,600,000 sq. ft. and a potential annual cultivation output of 100,000 kg [16].

Core Viewpoint - Cannara Biotech Inc. has received conditional approval to uplist its common shares to the Toronto Stock Exchange from the TSX Venture Exchange, marking a significant milestone for the company [1][2]. Company Overview - Cannara Biotech Inc. is a vertically integrated producer of premium-grade cannabis products, operating two mega facilities in Québec that span over 1,600,000 square feet [1][4]. - The company has the potential annualized cultivation output of 100,000 kg, leveraging Québec's low electricity costs to produce affordable premium-grade cannabis products [4]. Uplisting Details - The final approval for the uplisting is contingent upon the company meeting specific conditions set by the TSX, after which its common shares will be delisted from the TSXV [3]. - Cannara's common shares will continue to trade under the stock symbol "LOVE" once listed on the TSX, with a press release to follow confirming the expected commencement date for trading [3]. Management Commentary - The CEO of Cannara expressed gratitude towards employees, shareholders, and partners for their support, emphasizing the uplisting as a validation of the company's vision and efforts [2]. - The management anticipates that the uplisting will enhance visibility to potential new investors and provide greater liquidity for shareholders as the company continues to execute its growth and profitability strategy [2].

Core Insights - Cannara Biotech Inc. reported strong financial results for Q1 2026, with total revenues of $30.1 million, a 20% increase from $25.1 million in Q1 2025, driven by market share expansion and improved operational efficiency [5][8][12] - The company achieved a gross profit before fair value adjustments of $13.5 million, representing a 38% increase year-over-year, and an adjusted EBITDA of $8.8 million, up 47% compared to the same period last year [5][8][12] - Cannara's national retail market share reached 4.1% in Q1 2026, up from 3.8% in Q4 2025, with significant gains in key provinces, particularly Québec and Ontario [5][10][20] Financial Performance - Gross cannabis revenues before excise taxes increased to $41.8 million in Q1 2026 from $34.9 million in Q1 2025, a $6.9 million or 20% increase [8][12] - Total revenues, net of excise taxes, rose to $30.1 million in Q1 2026 from $25.1 million in Q1 2025, reflecting a $5.0 million or 20% increase [5][8] - Gross profit before fair value adjustments increased to $13.5 million in Q1 2026, up 38% from $9.8 million in Q1 2025, with a gross profit percentage of 45% [8][26] Operational Highlights - Cannara's operational strategy focuses on disciplined expansion, with the Valleyfield processing center on track for completion in Fiscal 2026 and three additional grow zones being prepared for Fiscal 2027 [5][12][11] - The company reported strong operating cash flow of $8.0 million in Q1 2026, supporting its capital allocation strategy [5][12] - The launch of new products, including vape cartridges, contributed to market share gains and brand recognition [13][15] Market Share Insights - The estimated national retail market share of Cannara increased to 4.1% in Q1 2026, with notable growth in Québec, where the company ranked 1 by December 2025 [5][10][20] - In comparison to Q1 2025, Cannara's market share in Québec rose to 13.5% from 12.5%, and in Ontario, it increased to 3.1% from 2.6% [21][23] - The company experienced a decrease in market share in Saskatchewan, down to 0.9% from 1.7% in Q1 2025, while Manitoba saw an increase to 1.4% from 0.9% [21][23]

Core Viewpoint - Cannara Biotech Inc. has qualified to trade its common shares on the OTCQX Best Market, enhancing its visibility and accessibility to U.S. investors while maintaining its listings on the TSX Venture Exchange and Frankfurt Stock Exchange [1][2][3]. Company Overview - Cannara Biotech Inc. is a vertically integrated producer of premium-grade cannabis products, operating two mega facilities in Québec that span over 1,650,000 sq. ft. [1][10]. - The company has the potential annualized cultivation output of 100,000 kg, leveraging Québec's low electricity costs to produce affordable premium-grade cannabis products [10]. Trading and Market Access - Effective January 14, 2026, Cannara's common shares will trade on OTCQX under the symbol "LOVFF", which is expected to enhance the company's exposure to institutional and retail investors in the U.S. [2][4]. - OTCQX is designed for established companies and requires adherence to high financial reporting standards and corporate governance practices [3]. Financial Disclosures - Cannara Biotech will release its financial results for Q1 2026 on January 26, 2026, at 7:00 a.m. ET, followed by a webcast at 11:00 a.m. ET [5][6]. Shareholder Engagement - The Annual General and Special Meeting of shareholders is scheduled for January 29, 2026, at 11:00 a.m. ET, to be held via live webcast [7][8].

Financial Data and Key Metrics Changes - The company reported over $700 million in annual sales, indicating significant growth potential in the consumer market [1] - The focus on profitability and cash flow generation remains strong despite challenges in the consumer demand landscape [22][24] Business Line Data and Key Metrics Changes - The Snug Sofa Collection was launched as a lower-priced entry point, expanding the product offerings beyond the traditional Sactionals [2][3] - A new high-end Sactional platform is set to launch in 2026, indicating a strategic move to diversify product offerings [4] Market Data and Key Metrics Changes - The company plans to reshore its Sactionals production from Asia to the United States, which is expected to enhance product quality and efficiency while maintaining margin neutrality [5][6] - The company is positioned to leverage its strong brand and product offerings in a competitive market, focusing on winning the living room segment [8][24] Company Strategy and Development Direction - The overarching strategy is to double or triple the company's growth, moving beyond a 10% annual growth target [22] - The company aims to harvest its brand and prepare for a significant launch into new product categories in the following fiscal year [8][24] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenges posed by tariffs and consumer uncertainty but emphasized a focus on long-term profitability and brand strength [22][24] - The company is optimistic about future growth opportunities, particularly with the potential recovery in the housing market [35] Other Important Information - The company has made significant investments in people, processes, and new stores to support its growth ambitions [20][22] - A new Chief Marketing Officer has been appointed to enhance brand storytelling and marketing strategies [17][18] Q&A Session Questions and Answers Question: Can you elaborate on the Made in America initiative and its impact on the business? - Management confirmed that the initiative allows for production in the U.S. at a margin-neutral basis, which is a strategic advantage given the current tariff environment [9][10][12] Question: What are the plans for store growth and omnichannel strategy? - The company is focusing on an omnichannel approach, emphasizing both digital presence and physical showrooms to enhance customer experience [28][30] Question: How does the company plan to leverage recent investments for future growth? - Management indicated that investments are aimed at achieving significant sales growth while maintaining profitability, with a focus on brand strength and market share [22][24]

Financial Data and Key Metrics Changes - The company reported over $700 million in annual sales, indicating significant growth potential in the consumer market [1] - The focus on profitability and cash flow generation remains strong despite challenges in the consumer demand landscape [22][24] Business Line Data and Key Metrics Changes - The Snug Sofa Collection was launched, aimed at a lower price point, expanding the product offering beyond traditional sectionals [2][3] - A new high-end sectional platform is set to launch in 2026, diversifying the product range further [4] Market Data and Key Metrics Changes - The company plans to reshore over 80% of its sectional production from Asia to the United States, which is expected to enhance product quality and efficiency [5][6] - The strategy to onshore production is seen as a way to mitigate tariff impacts and improve margins [9][12] Company Strategy and Development Direction - The overarching strategy is to "win the living room" and expand into new rooms in the future, focusing on brand strength and customer loyalty [8][24] - The company is investing in marketing and brand positioning to support growth, with a new CMO brought in to enhance storytelling and brand presence [17][18] Management's Comments on Operating Environment and Future Outlook - Management acknowledges the challenges posed by a declining category and intense promotional environment but remains optimistic about future growth opportunities [22][23] - The company aims for double-digit growth in the long term, focusing on brand expansion and market share acquisition [25][26] Other Important Information - The company emphasizes the importance of repeat customers and the potential for easier customer acquisition through existing loyal customers [34] - The partnership with Costco is highlighted as a successful omnichannel strategy, enhancing brand visibility and sales [31][32] Q&A Session Summary Question: Can you elaborate on the made in America initiative and its impact on business? - The company plans to manufacture in the U.S. in a margin-neutral way, which will not be significantly affected by tariff changes [9][10] Question: What investments are needed to support growth? - The focus is on maintaining investments that will allow for significant growth while balancing profitability and cash flow [22][24] Question: How does the company plan to grow its store presence and omnichannel strategy? - The strategy involves optimizing the number of physical stores while enhancing the digital customer experience and leveraging partnerships for broader reach [28][30]

Financial Data and Key Metrics Changes - The company reported over $700 million in annual sales, indicating significant growth potential in the consumer market [1] - The focus for the upcoming year is on achieving profitable sales growth and maintaining a strong balance sheet despite challenges in the market [22][25] Business Line Data and Key Metrics Changes - The Snug Sofa Collection was launched in 2025, aimed at a lower price point, and will expand into a full sectional platform in 2026 [2][4] - A new high-end sectional platform is also set to launch in 2026, diversifying the product offerings [4] Market Data and Key Metrics Changes - The company plans to reshore its entire sectionals production back to the United States, which is expected to enhance product quality and efficiency while remaining margin-neutral [5][7] - The company is positioned to benefit from a potential recovery in the housing market, which could positively impact sales [1][34] Company Strategy and Development Direction - The overarching strategy is to "win the living room" and expand into new rooms in the future, focusing on brand strength and customer loyalty [8][23] - The company is investing in marketing and brand positioning to enhance its presence and storytelling in the market [18][19] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenges posed by tariffs and consumer uncertainty but emphasized a focus on long-term profitability and cash flow generation [22][24] - The company is optimistic about future growth, aiming for double-digit growth in the top line without relying on category support [24] Other Important Information - The company has made significant investments in people, processes, and new stores over the past few years to position itself for future growth [20][21] - The new CMO, Heidi Cooley, is expected to play a crucial role in evolving the brand's messaging and marketing strategies [17] Q&A Session Summary Question: Can you elaborate on the made in America initiative and its impact on the business? - Management confirmed that the reshoring initiative will allow for production in a margin-neutral way, enhancing product quality and reducing reliance on tariffs [9][10][12] Question: What are the plans for store growth and omnichannel strategy? - The company is focusing on an omnichannel approach, balancing digital presence with physical showrooms to enhance customer experience [26][28][30] Question: How does the company plan to leverage past investments for future growth? - Management stated that the goal is to double or triple the company, focusing on profitable sales growth and maintaining a strong balance sheet despite market challenges [21][22][24]

Core Insights - The Lovesac Company is scheduled to participate in the 2026 ICR Conference on January 12, 2026, at 11:00 a.m. Eastern Time [1] - The event will be webcast live and archived on the Company's Investor Relations website [2] Company Overview - The Lovesac Company, based in Stamford, Connecticut, is a technology-driven furniture brand known for its modular couches called Sactionals, designed to be adaptable and long-lasting [3] - The product lineup includes Sactionals, Sactionals Reclining seat, premium foam beanbag chairs (Sacs), PillowSac Chair, StealthTech home theater system, and Snugg™ sofa seating solution [3] - The brand emphasizes responsible production and innovation, having received awards for sustainability and product design, and holds a robust portfolio of utility and design patents [3] - Products are primarily sold online through the official website, complemented by physical retail locations and partnerships with third-party retailers [3]